# MASSACHUSETTS GENERAL HOSPITAL: Disulfiram/Copper as a Dual Senolytic Strategy Targeting Tumor and Immune Cell Senescence in Chordoma

**Lab Budget Score:** 70/100

| Field | Value |
|---|---|
| Organization | MASSACHUSETTS GENERAL HOSPITAL |
| Location | BOSTON, MA |
| Project | Disulfiram/Copper as a Dual Senolytic Strategy Targeting Tumor and Immune Cell Senescence in Chordoma |
| Project number | 1U01FD008980-01 |
| Mechanism | U01 |
| Institute | Food and Drug Administration |
| Award | $1,000,000 |
| Awarded | 2026-09-30 |
| Project period | 2026-09-30 to 2028-08-31 |
| UEI | FLJ7DQKLL226 |

## Why this score
- Award of $1M or more.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11571230). Last refreshed: 2026-11-04T21:37:56.465Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.